Director of the OMRF Multiple Sclerosis Center of Excellence, where MS is approached with optimal clinical care and scientific innovation. Opinions are my own.
USA
Joined March 2011
- Tweets417
- Following159
- Followers1.1K
- Likes224
Dr. Gabriel Pardo retweeted
EBV is required for the development of multiple sclerosis, but it’s not known how a common virus leads to disease. 3 exciting new papers in @CellCellPress provide major insights into how this may occur:
Dr. Gabriel Pardo retweeted
Repairing MS: The Quest to Rebuild Myelin
New MS Living Well Podcast🎙️Guests: Veronique Miron PhD🇨🇦 @UofT & Rob Glanzman MD 🇺🇸
bit.ly/47BfjJ8 🍏apple.co/3JUhTQz
@MSCanOfficial @DrJim4MS @MStranslate @DocforMS @DrJNicholas Sponsor: @TGTherapeutics
Dr. Gabriel Pardo retweeted
#ECTRIMS2025 coming up in Sept. 24-26 in Barcelona. Off to Toronto, Canada in 2026! ⛸️ Advances in #MS🌲#ECTRIMS2026! 🇨🇦
@AlexMuccilli @MSDoc_Freedman @DocforMS @DrJNicholas @Brandon_Beaber @C_OrejaGuevara @KlausSchmierer @J_SastreGarriga @bart_professor @anneke_vdw @ECTRIMS
Dr. Gabriel Pardo retweeted
🚀Boosting Brain Health: Blueprint for MS
New MS Living Well Podcast 🎧🚶♀️🥗😴🧘♀️
bit.ly/3FyR2b0🍏apple.co/4jHbiow
@KlausSchmierer @DocforMS @anneke_vdw @C_OrejaGuevara @ahmedzobeidat @bart_professor Sponsor: @TGTherapeutics
Dr. Gabriel Pardo retweeted
How can functional, anatomic, and biologic tools optimize treatment and risk mitigation for people with progressive #multiplesclerosis? Read Dr. Pardo's (@DocforMS) review article in our February issue.
practicalneurology.com/artic…
@OMRF @mscare @mssociety @AANmember @ACTRIMS @ACPIMPhysicians #MS
Dr. Gabriel Pardo retweeted
Thought-provoking discussion about gaps in MS treatments and the role of microglia and CNS targeting therapies by @DocforMS at #TNSW2025 @Texas_Neuros
Dr. Gabriel Pardo retweeted
Have you ever wondered about the magnitude of new/unused disease modifying therapies for multiple sclerosis that may be out there? Retail costs for these specialty medicines are near $100K per year!
This is a before and after photo from 2020. Imagine for a minute what we have collected up to present day.
Enthusiasm for fixing the problem is low especially when compensation has already occurred along the distribution chain.
@davidbalat @patientsrising @ectrims @actrims @mssociety @docforms @DrugChannels @elonmusk
Dr. Gabriel Pardo retweeted
MS & The Spinal Cord; New MS Living Well podcast🎙️
Guests: Drs. Cree & De Luca. 80% of people with #MS have spinal cord lesions on MRI.
bit.ly/4dsbd68🍎apple.co/3MfHFN3
@KlausSchmierer @C_OrejaGuevara @Brandon_Beaber @themsguide @MustStopMS @DocforMS @jsabatino37
Dr. Gabriel Pardo retweeted
Dr. Yang Mao-Draayer will serve as director of clinical and experimental therapeutics in OMRF’s Arthritis and Clinical Immunology Research Program. She also will treat MS patients and direct OMRF’s neuroimmunology lab.
Read more: omrf.org/2024/05/30/omrf-wel…
Dr. Gabriel Pardo retweeted
Dr. Robert and Nancy Ellis were honored with the MS Advocate Award for their support of OMRF’s Multiple Sclerosis Center of Excellence since its opening more than a decade ago.
The event raised more than $450,000 for MS!
omrf.org/2024/05/10/omrf-din…
Dr. Gabriel Pardo retweeted
Uncommon #MS #Symptoms: New MS Living Well Podcast! Trigeminal neuralgia, MS hug, Lhermitte's, Uhthoff's, vertigo, sex/bowel issues & more.
bit.ly/4a9cmwH🍏apple.co/3UuorqA
@DrJim4MS @DrJNicholas @DocforMS @jsabatino37 @KlausSchmierer @C_OrejaGuevara @anneke_vdw
Dr. Gabriel Pardo retweeted
Over a 6-year treatment period, ofatumumab (@Novartis) resulted in sustained efficacy in recently diagnosed, treatment-naive patients w/ relapsing #multiplesclerosis.
Details: neurologylive.com/view/ofatu…
Dr. Gabriel Pardo retweeted
Nobody knows the Central Nervous System like the “Central State” of Oklahoma 🧠 Thrilled to meet up with fellow Oklahoman and fantastic MS specialist Gabriel Pardo from Oklahoma Medical Research Foundation (OMRF) @DocforMS #AANAM2024
Dr. Gabriel Pardo retweeted
Early treatment works in pediatric MS. This observational study of 5,224 children with MS found high-efficacy treatment in those with minimal disability reduced disability progression by 59% while modestly effective therapy reduced disability by 35% pubmed.ncbi.nlm.nih.gov/3854…
Dr. Gabriel Pardo retweeted
🚀Revolutionizing #MS Care: #B-Cell Therapy 🩺
New MS Living Well podcast; Drs. Hauser & @hwiendl
bit.ly/4bjvTMI🍎apple.co/48TV7jf
@Brandon_Beaber @TZiemssen @NeleHandwerker @KlausSchmierer @DrJNicholas @DocforMS @DrJim4MS @MSViewsandNews Sponsor: @TGTherapeutics
Dr. Gabriel Pardo retweeted
Set your ⏰ for 11:00a this am, Sat 10/28! That's in less than 4 hours! Join me for our October LIVE STREAM! Ask-Me-Anything Multiple Sclerosis! @YouTube
Dr. Gabriel Pardo retweeted
The @NIH has awarded OMRF $6.4 million to support an Institutional Development Award (IDeA) Center of Biomedical Research Excellence (COBRE). The Phase 3 grant will expand developmental biology research in Oklahoma ⤵️ omrf.org/2023/10/19/omrf-rec…
Dr. Gabriel Pardo retweeted
Making Strides: Enhancing MS Mobility 🎧♿️👩🦯
NEW MS Living Well Podcast: @DrGretchenPT
& Annie Morrow DPT @paraquad
bit.ly/48N5mpP 🍎apple.co/46Mvf7D
@DanJenDig @MarkWebb_ @RachelHorne19 @nclark140 @MS_Stumbling @TheMSKittylady @DrJim4MS @DrJNicholas @DocforMS
Dr. Gabriel Pardo retweeted
The OMRF team got together last week to commemorate the 77 for 77 campaign in a big way! Each face you see here is someone who is working to make discoveries that make a difference for Oklahomans and people everywhere.
➡️ omrf.org/77 ⬅️
Dr. Gabriel Pardo retweeted
📢 I am very excited to introduce to you, our new virtual #MS seminar series. Our Inaugural speaker is Dr. Nancy L. Sicotte, MD. Please DM if you want to attend virtually and please RT to colleagues. @AANmember @mssociety @cemcat_em @DanOntaneda @Brandon_Beaber @drbarrysinger
